跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DDC-4
首页
药物
DDC-4
DDC-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of schisantherin A in preparation of medicine for treating cholestatic liver disease
申请人: SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV TCM
优先权: 2022
CN
Hexahydro-pyrazino-pyridino-indole dione, and its synthesis and use
申请人: CAPTIAL MEDICAL UNIV
优先权: 2004
CN
High-crystallinity allocholic acid and application of high-crystallinity allocholic acid in preparation of medicine for preventing and treating cholestatic liver disease
申请人: UNIV SOUTH CHINA TECH
优先权: 2023
CN
Hexahydro-pyrazino-pyridino-indole, and its systhesis and use
申请人: CAPITAL MEDICAL UNIV
优先权: 2004
CN
药物
反馈